DNAPrint may also participate in the pharmaceutical company expansion into genomics by partnering its ADMIXMAP platform, and/or sharing with the pharmaceutical industry new drug targets/indications that are discovered in house. DNAPrint also expects to enter into collaborations with leading pharmaceutical companies to conduct pre-clinical pharmacogenomics research on new drugs in their pipelines.
News 
Market Data 
Discover 
AI
